secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2026-09-22T11:05:43+00:00
Accession:  0001493152-26-043644
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix adds 21M Medicare lives for TONMYA; total coverage now 32M Medicare lives
-------------------------------------------------------------------------------

- Second major managed Medicare agreement effective immediately adds ~21M lives (38% of ~55M Medicare lives).
- Medicare coverage now 32M lives (58% of Medicare); total commercial and government coverage reaches ~166M lives (53% of 314M U.S. lives).
- Builds on prior commercial payer agreements with two GPOs and one major managed Medicare agreement; TONMYA also covered by Medicaid in nearly all states.
- First fibromyalgia treatment approved in over 15 years; management highlights expanding patient access for TONMYA launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226043644/0001493152-26-043644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000149315226043644/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer